English 中文

Qiang Xu

Shasha Dai

Ms. Shasha Dai is an analyst of Decheng Capital and has been with the firm since October 2016. Prior to joining Decheng Capital, Ms. Dai was an investment banking analyst in Morgan Stanley Hong Kong, where she was responsible for transactions in healthcare sector including IPO, M&A, privatization and block trades, etc. Ms. Dai has once participated in the IPO of PW Medtech (1358.HK) and Universal Health (02211.HK), privatization of Biosensors, and block trade transactions of leading Chinese healthcare sector players including CSPC, Luye Pharma Group, Phoenix Healthcare, etc. Ms. Dai received her Master degree in Finance from Shanghai Advanced Institute of Finance (SAIF), Shanghai Jiao Tong University and a BE degree in Ocean Engineering from Shanghai Jiao Tong University



Min CuiMin Cui, Ph.D.
Managing Director
Dan ZabrowskiDan Zabrowski, Ph.D.
Venture Partner
Victor E. Tong, Jr.Victor E. Tong, Jr.
Ted DriscollTed Driscoll, Ph.D.
Qiang XuQiang Xu, Ph.D.
Nick PliamNick Pliam, M.D., Ph.D.

Tony TongTony Tong, Ph.D.
Vice President

Shasha DaiShasha Dai
Copyright © 2011 Decheng Capital LLC. All Rights Reserved.